Fundación CIDEA - Buenos Aires

Para la investigación y difusión de las enfermedades alérgicas, respiratorias y otras. Institución afiliada a la Facultad de Medicina de la Universidad de Buenos Aires.
logoFundación CIDEA - Buenos Aires
Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina
Select an option

Our team

Medical staff
Monica Silvia De Gennaro
Jorge Máspero
Investigadora PrincipalAndrea Rosana Baños
Legal and Administrative staff
QAMaria Ines Antunez
Study Coordinator Julieta Peverini

Open studies

Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia TherapeuticsSee more
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma - INC 54707-208 - Incyte CorporationSee more
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) - Regeneron PharmaceuticalsSee more
Dermatitis
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis - ADorable-1 - Dermira, Inc.See more
Lupus
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) - POETYK SLE-1 - Bristol-Myers SquibbSee more
Urticaria
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines - Novartis PharmaceuticalsSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy